Clinical Trial Update: Evaluate the Safety of Linaclotide in IBS-C Patients in China

View source ↗

Summary

A completed clinical trial assessing the safety of Linaclotide in patients with irritable bowel syndrome with constipation (IBS-C) in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

Sponsor: AstraZeneca | Conditions: Irritable Bowel Syndrome-IBS | Status: COMPLETED